http://www.biotechdaily.com.au/pages/back-copies.php

Back copies

View recent copies of Biotech Daily with important stories on research and development (R&D), mergers and acquisitions (M&A), finance, government grants and regulation, share price movements, industry news and personnel appointments in Australian Stock Exchange listed biotechnology companies.

 

December 1, 2008
November BDI-40:
Close To The Bone

 

 

November 21, 2008
Progen, Medigen, $70m Cash & The $2m Milestone; Optiscan In Prostate Surgery; FDA Clears Sunshine Heart Trial		November 20, 2008
Stem Cell's 'Significant' Pfizer Deal; Benitec Loses Staff; Heartware Implants 2nd Heart Pump 		November 19, 2008
Dr Mervyn Jacobson Redirects Genetic Technologies; Cathrx Starts Australian Trial; Lab Data Backs Neurodiscovery Pain Drug
November 18, 2008
Victoria Gov Funds Zebrafish Unit; Prana PBT1 Blocks Anaesthetic Patholgy In Mice; NSW Breast Cancer Institute Adopts Impedimed's L-Dex   		November 17, 2008
Biota Phase III Lani Trials Ready; Cytopia Doses 1st Brain Cancer Patient; Medical Therapies Offers 4c Share Plan		November 14, 2008
Bio-Guide Brief: Progen's Beerworth Review On The Money; Progen Coup Group Wins EGM; Stem Cell Wins Euro-Patent Appeal
November 13, 2008
Progen To Return $30m To Investors; 5 Patrys Products Show Cancer Potential 		November 12, 2008
Polish Study: Polartechnics' Superior Cervical Cancer Test; Phosphagenics, Acrux Trial NSAIDs; Stem Cell $1.1m Licence		November 11, 2008
Canada Approves Tissue Therapies Trial, WA Patients Improve; Ausbiotech Broadsides Federal Government; Progen Coup Group's Demands 
November 10, 2008
Progen Investors Narrowly Miss Coup Meeting; Ellex Laser 'Safe, Effective' For Diabetic Macular Oedema		November 7, 2008
Biotech Daily Is Three; Division At Living Cell AGM; OMI Raises $503k		November 6, 2008
FDA Extends Ventracor Trial, Revenue 'A Record'; Arana Loses CEO Dr John Chiplin 
November 5, 2008
Ventracor Implants 100th Euro Patient, Cannula CE Mark; Mesoblast Phase I/II Bone Marrow Trial 		November 4, 2008
Pharmaust, Curtin Univ Of Technology Collaborate On Diabetes  		November 3, 2008
Gloomy October: Living Cell Up 16%, Optiscan Down 67%; Adieu Apollo; FDA OK For Arana Trial
October 31, 2008
Genetic Technologies Fixes Cancer Test Prices; Giaconda Loses $40m Hope 		October 30, 2008
Most Alchemia Projects On Hold; White Knight Saves Norwood Abbey 		October 29, 2008
Novogen's Phenoxodiol, N128 Cancer Synergies; Biota Board Decision-Making Questioned; Advanced Surgical's 1st European Use
October 28, 2008
Alchemia Slashes 60% Of Staff; Prof Trounson's $US3bn Stem Cell Institute; Living Cell '3-5 Years To Market'; Ventracor Tightens Belts  		October 27, 2008
Ventracor Bioguide: A Heart Beat Away; Stem Cell's Embryo-Free Pluripotent Cells; AusBiotech Conference Opens		October 24, 2008
Biota Chair John Grant Late Mind-Change On Vote; Hunter Hall Takes 12% Of Biota; Bioprospect Resists Solagran Coup; Fluorotechnics Raises $8m
October 23, 2008
Benitec 'Very Encouraged' By RNAi HIV Trial; Genetic Technologies' Cancer Tests Challenged; FDA Approves Alchemia Phase III Cancer Trial 

October 22, 2008
Grahame Leonard Upsets Genetic Techno Spill Bid; Exclusive: Dr Mervyn Jacobson Explains; Anadis Studies Biogard For HIV

October 21, 2008
Living Cell Jumps 64% On NZ Xenotransplant Trial; US Patent For Alchemia
October 20, 2008
Fed Gov Releases Pharmaceutical Industry Report; Tissue Therapies Claims 'Exceptional' Results		October 17, 2008
Incitive Meets Rough End Of Biotech Pineapple; Cyclopharm Rights Issue For $3.2m		October 16, 2008

FDA Clears Impedimed’s L-DEX U400; Paul Keating In Brain Election; Optiscan Falls 39% 

October 15, 2008
Antisense ATL1101 Suppresses Human Prostate Tumors In Mice; Genera Claims Superior HPV Test; Bio-Guide: Chemgenex' Pacific Gulf		October 14, 2008
Imclone Names Cancer Candidate From Circadian Target; IDT's Geoffrey Lord Buys His 2.5m 'Lost' Shares		October 13, 2008
Mesoblast Up 20% On Cardiac Trial Data; US 2nd Request To CSL On Talecris; Chemgenex Plan Raises $128k
October 10, 2008
Immugene Vaccine Protects Pigs; IM Medical Takes Heart Test To Mines		October 9, 2008
Biomd Implants 10th Bovine Heart Patch; Arana Appoints Gordon Black; Buys Back Shares		October 8, 2008
Stem Cell Licences Cambridge Technology; Ausbiotech Conference; Brainz Shuts Down
October 7, 2008
Halcygen 1/2 Dose Super Generic Matches Sporanox; Agenix Notes, Placement To Raise $800k		October 6, 2008
Nathan Drona Chairs Avexa; Impedimed's US Awareness Campaign 		October 3, 2008
Impedimed Supplies US Lifestyle Co; Pharmaxis Takes 12 Abstracts To Berlin Meeting; Solagran Tightens Control Of Bioprospect
October 2, 2008
Bio-Guide: Phosphagenics' Very Deep Vitamin E Pipeline; Arana Superhumanizes Circadian's VEFG-D Antibody; Psivida Medidur Results 'Very Encouraging' 		October 1, 2008
Grey September: Biotechs Down, Sunshine Up 80%; Pharmaxis Files Bronchitol Marketing Application; Synchrotron Rapid Access		September 30, 2008
Arana Files Rheumatoid Arthritis Drug IND; Advanced Ocular Sells Patents For $US2m; Neurodiscovery Part-Time CEO Starts On $203k
September 29, 2008
Alchemia Cancer Drug IND To FDA; Biota's Peter Molloy Appointed Viralytics Director		September 26, 2008
Norwood Immunology's Stem Cell Strategy; Review Backs Psivida Phase III Trial 		September 25, 2008
Cochlear Fights Union; Sunshine Wins FDA Rebate; Xenome Begins Pain Trial 
September 24, 2008
ASX Queries Director's Statements; AGM Votes On New Sunshine Chairman's 2m Options		September 23, 2008
Phosphagenics Starts Phase I Lidocaine Trial; Heartware Meets FDA Conditions; Clinuvel Begins 5th CUV1647 Trial		September 22, 2008
Vale Jeff Wassetheil
Genetic Tech Board: Sack The CEO, We Walk; Police Investigate Bioprospect's Snr Sgt Tony Langdon 
September 19, 2008
Editorial: Friends Of Mervyn & The Perils Of Owner-Drivers; Anadis, Tatura Milk Collaborate On Export 		September 18, 2008
Dr Mervyn Jacobson Spills Genetic Technologies' Board; Biopharmica WAIMR Develop Cancer Drug; Fed Gov $60m Bio-Venture Capitalism		September 17, 2008
Cathrx Sells 1st Product; Chemgenex Raises $13m; Virax Partner Posts Positive Cancer Data 
September 16, 2008
Agenix Sues Leggets For $4m; Immune Data Backs Biodiem's LAIV For 'Flu; Bionomics BNC105 Shows Anti-Tumor Activity		September 15, 2008
Agenix Alleges 'Breach Of Duty' Against ex-CEO Neil Leggett; China Grants Labtech Patent; Norwood Reformation		September 12, 2008
Virax Hit By Roche-Transgene Delay; Agenix Director In 'Impropriety' Case; Sunshine Heart Trial Approved
September 11, 2008
Viralytics 'Encouraged' By 2 Cavatak Studies; Eastland Expects Good Malaria Results		September 10, 2008
Biolayer, Prince Of Wales Collaborate On Neuro-Diagnostics; Bio-Guide Brief: Starpharma; Ellex German Sales		September 9, 2008
Cutler Innovation Review; Starpharma Up 60% On $100m Condom Deal; Peplin Starts Phase III
September 8, 2008
Nasdaq Sends Progen 'Deficiency Notice'; Merrill Lynch Takes 5.5% of Arana; Australian Stem Cell Centre Interim Board		September 5, 2008
Polartechnics, Genera, Healthscope Partner On HPV; Aust Stem Cell Centre Loses Board; Solagran Down 32% On Info Night		September 4, 2008
Phylogica, Cambridge Partner on Cancer; Anadis Develops HIV Therapy; Fluorotechnics IPO
September 3, 2008
Tissue Therapies Trial Shows 'Marked Improvement'; Israel Approves Anadis Trial; Spinifex Raises $12m 		September 2, 2008
Stem Cell: 'World 1st True Rat Embryonic Cells'; Bio-Guide - Mergers; Ventracor's Peter Crosby On The Roadshow		September 1, 2008
Bio-Spring: BDI-20 Up 14.3%, Big Caps Up 29%; Bionomics Reduces Anxiety In 3 Species; FDA Okays Cytopia Trial
August 29, 2008
Agenix Requests 'Up To 2 Months' Suspension; Medical Therapies Sets Out Program		August 28, 2008
Ventracor Revenue Up 163% To $20m; Arana Completes Psoriasis Recruitment		August 27, 2008
Phylogica Improves Potency, Duration; Neuren Divests Cancer Program 
August 26, 2008
Neurodiscovery Drug 'Effective In Pain Relief'; Avexa Takes Greater Control of ATC		August 25, 2008
Prima To Meet FDA For Cancer Drug; Cellestis $2.25m Maiden Profit

August 22, 2008
If Marc Sinatra Was King Of Circadian

August 21, 2008
Mesoblast Benefits From FDA Spinal Fusion Warning; Heartware Implants 1st US Pump		August 20, 2008
Anadis Spray 'Switches-Off' Flu Virus Replication; Pharmaxis Bronchitol 'Safe' At 12 Months		August 19, 2008
Peplin Appoints Tom Wiggans CEO, Raises $24m; Uscom Boosts Transplant Organs 15%
August 18, 2008
Dr Ian Nisbet Reforms Xenome For 2009 IPO; Bio-Guide Brief: Acrux		August 15, 2008
Schering-Plough Halts Two Acrux programs; IDT Profit Up 30% to $7m		August 14, 2008
Acrux Orion Alliance; Polartechnics Truscreen Demand Up, Results Better, US Interest
August 13, 2008
CSL Buys Talecris Plasma For $3.1b, Profit Up 30% To $702m; Starpharma Trials Vivagel's Antiviral Retention		August 12, 2008
Bronchitol Improves Cystic Fibrosis Lung Function; Acrux Expands KV Deal; Mesoblast Grows Cartilage In Sheep		August 11, 2008
Tissue Therapies Treats 1st Patient; Biota Challenges Common Cold
August 8, 2008
Sth Africa Approves Virax HIV Vaccine Trial; NZ Patent For Benitec RNA		August 7, 2008
CEO Interview: Bionomics' Dr Deborah Rathjen; Biotron Begins Hep C Human Trials 		August 6, 2008
Monash Opens $11m Monoclonal Antibody Facility; Mesoblast Claims Long Bone Stem Cell Success
August 5, 2008
FDA Backs QRX Phase III Plan; Antisense: ATL1102 Different From Tysabri; Comment 		August 4, 2008
Antisense In Tysabri Trading Halt; Journal Backs Uscom For Paediatrics 

August 1, 2008
July BDI-20 Beats All Ords, Again: Heartware Up 54%, Progen Down 55%

July 30, 2008
Lancet Publishes Prana Alzheimer's Efficacy Data; Impedimed Sales up 109%

July 29, 2008
Avantogen Wants Funds For Hawaii; Clinuvel's 1st US Approval

July 28, 2008
Agenix China's Heads To Roll

July 24, 2008
Cytopia Bioguide - Flying Under The Radar; Biota's Relenza Royalties Tumble; Landlord Shanghais Agenix

July 23, 2008
Progen Halts Phase III Cancer Trial; Bio-Guide Brief; Antisense Competitor Triples Sales; Bionics Conference, Bionic Eye Development 

July 22, 2008
Living Cell: 'Benefit In All Type 1 Diabetes Patients; Anadis Renews Tel Aviv IBD Trial

July 21, 2008
Biota Loses GSK Court Gamble; Bio-Guide Brief; Advanced Surgical Device Used in Cardiac Surgery 

July 18, 2008
Metabolic Becomes Polynovo With $18m Cash; Editorial: A Marriage Made In Bio-Heaven

July 17, 2008
Astrazeneca's Medimmune  Evaluates Norwwod Vaccine; Viralytics New Directions; Prana Big In Chicago

July 15, 2008
Proteome Halts Prostate Ca Test; Circadian Takes 100% of Vegenics

July 11, 2008
Genetic Techno Enforces Breast, Ovarian Ca Test Rights

July 10, 2008
Graeme Kaufman: $400m Fund Delayed, But Still Bullish; Mesoblast Stem  Cells for Eye Disease

July 9, 2008
Tissue Therapies To Start Perth Trial; Starpharma's Vivagel for Vaginosis

July 8, 2008
Giaconda Halts Hep C Trial

July 7, 2008
Hunter Immunology Applies for FDA Phase III COPD Trial; Psivida Starts Phase IIb Pancreatic Ca Trial

July 3, 2008
Avita Close To China Registration; Medical Therapies Buys Midkine Assets

July 2, 2008
Progen Spins Out Pharmasynth; TGA Approves Safety Med Pen Cap; FMR Fidelity Drop 4% of Cochlear in June

July 1, 2008
June Top 20 Beats All Ords; Chemgenex Submits Part 1 of IND; $16m For Unilife's Syringe 

June 30, 2008
Antisense Phase II MS Drug Success

June 27, 2008
Biopharmica Finds 43 New Cancer Leads

June 25, 2008
Living  Cell Pig Insulin Detected In Patients; Peplin Doses 1st AK Patient 

June 24, 2008
Opposition, Industry Protest Grant Axing; Acrux Begins Phase III Testosterone Trial

June 23, 2008
Alchemia Heparin Delayed; Novogen Licences Isoflavonoid to Spanish Fleet

June 20, 2008
Pharmaxis To Start FDA Phase III Bronchiectasis Trial; Metabolic Shuts Programs, Looks For Acquisitions

June 19, 2008
Bionomics in Multiple $50m Deals; NSW-Vic Fund Stem Cell Research; Victoria-California Stem Cell Alliance

June 18, 2008
Victoria Buys $100m Supercomputer; Stem Cell Licences Protein

June 17, 2008
Chemgenex Drug Efficacy in 2nd Indication; Victoria-New Zealand $30m Bio-Fund; Bronchitol Limited Availability

June 16, 2008
Florey Imaging Detects Huntington's; Cellestis Expects $2m Maiden Profit

June 13, 2008
Boss Interview: Mesoblast's Silviu Itescu; Bioguide - Circadian Changes It's Rhythm 

June 11, 2008
Circadian Now A VEGF Cancer Drug Co; Halcygen Anti-Fungal May Have Anti-Tumor Function

June 10, 2008
Peplin Halts US IPO, Chemgenex Mops Up IP

June 6, 2008
Benitec RNAi Markers Detected In HIV Patients

June 5, 2008
FDA Clears Mesoblast Phase II Cardiac Trial; Living Cell Expands Diabetes Trial

June 4, 2008
Starpharma Bio-Guide: Much More Than Vivagel; Avexa to Develop Hep C Drug

June 3, 2008
Cancer Study Backs Sirtex Sir-Spheres;

June 2, 2008
May Top 40 Down,
Heartware Up 40%

May 29, 2008
Govt Rejects
Ausbiotech Call
For Last Grants

May 28, 2008
Proteome, Agilent In
High-Tech Contra Deal;
Fermiscan Buys
Breast Clinic

May 26, 2008
CSL's Brian McNamee
Heads Industry Review;
All Change at Biolayer;
Network Appoints Michelle
Gallaher CEO

May 23, 2008
Heartware Raises $30m;
Contracts Halt
Benitec $5m Rights Issue

May 20, 2008
Evado Launches
Safe Cheap Trials
Software

May 16, 2008
Pfizer's Doors Open
To Aussie Biotechs

May 14, 2008
Budget Little Joy
For Biotechs;
Prima on Road
to Recovery

May 9, 2008
Fermiscan Breast Cancer
Test 69-75% Accurate

May 7, 200
Starpharma's Jackie Fairley -
Leader of the Dendrimer Pack;
Phosphagenics Raises $9m

May 6, 2008
Prana Targets
Parkinson's

May 5, 2008
Chemgenex Revisited;
QRX Dual Opiod
Beats Placebo

May 1, 2008
April Top 20 Up 9%;
Biomd Bovine Cardiocel
In Humans

April 30, 2008
Phosphagenics TPM
Anaesthetic Beats Control;
Genera To Raise $5m
For Women's Health
Diagnostics

April 29, 2008
Benitec Has Options
On 5 RNAi HIV Patents;
Dr Roland Scollay
Quits Metabolic

April 23, 2008
Tissue Therapies Trial 4 Months Late;
Uscom Posts 1st
Positive Cash Flow

April 22, 2008
Benitec Wins 4-Year Court Battle;
US Rebate Gives Compumedics
$30m Market

April 18, 2008
Sirtex Wins UWA,
Dr Bruce Gray Case

April 17, 2008
Marc Sinatra: Living Cell
- Regulator The Hurdle;
Patrys Trials 2 Antibodies
Across Several Cancers

April 16, 2008
Novogen Tragets Resistant
Ovarian Cancer;
Pharmaxis Delayed
At Least 1 Year

April 15, 2008
Acrux Evamist On Sale In US

April 14, 2008
Trial Results:
Bionomics Active Against
6 Cancers In Mice;
Novogen Potent In Mice;
Heartware Claims 91% Success;
Ventracor Claims 86% Success

April 10, 2008
ASX In Wonderland:
Is Solagran's 42% Material?

April 8, 2008
Opes Prime's Magnum Opus:
Shares belong to ANZ, Merrill;
Ross Dobinson's Exposure;
Missing NAL Shares

April 7
Mesoblast Treats 1st
Cardiac Patient

April 4
Opes Prime:
Caveat Bloody Emptor

April 3
FDA Backs Acrux More
Better Sex Spray

April 2, 2008
Opes Prime Hits Solagran,
Bioprospect; Heartware Takes Glancing Blow;
Uscom Standard of Care

April 1, 2008
Biotechs Fall In March;
Short Selling Or Selling
Yourself Short?

March 31, 2008
Margin Lending: Opes Prime
And Biotechs; Living Cell Trial
Shows Safety, Efficacy

March 28, 2008
Olympic Committee Endorses
Pharmaxis' Aridol

March 25, 2008
Novogen: Promensil Beats HRT, Yale Backs Ca Drug;
Agenix $2.5m To Sell Thromboview;
Alchemia, GSK Benefit From
FDA Heparin Warning

March 20, 2008
Marc Sinatra's Bioguide:
Cellestis - A Quiet Achiever

March 18,2008
Apollo - Global Downturn's
1st Australian Biotech Scalp

March 17,2008
Arana Begins Phase II
Anit-TNF Psoriasis Trial

March 12, 2008
Avexa's ATC 'Clears 90% Of
HIV In 48 Weeks'

March 11,2008
Chemgenex Begins French
AML Trial; Hawken Pays $1.5m
For 2 Biosignal Licences

March 4, 2008
Leon Serry: Retirement
Starts With A 12-Hour Day

March 3, 2008
Biotechs Recover in February

Feb 26
Prana Up 54% On
Alzheimer's Disease
Cognitive Success

Feb 21
Starpharma Still Standing
As 2 HIV Trials Stumble
Healthlinx Early Ovarian
Cancer Test ‘Superior

Feb 15
Cellestis Tb Test
‘6-Fold Better
Than Mantoux’

Feb 14
Marc Sinatra’s Bioguide:
Alchemia
– All Aboard For $1.60
‘Unexpected’ Efficacy Of
Solagran’s
Ropren For Alcoholism

Feb 11
Antisense Ms Drug
In Potential
$US100m Licence

Feb 1 , 2008
January Cruel To Biotechs;
Bargains Galore


Jan 31, 2008
Sienna Develops Pan-Cancer test

Jan 30 , 2008
Phosphagenics APA-01 Reduces Mouse Cholesterol

Jan 29, 2008
Psivida Claims Brachysil
Efficacy for Pancreatic Cancer

Jan 23, 2008
Companies Tickle Depressing Results

Jan 21, 2008
Living Cell In Top 20; Impedimed, Cathrx Join Top 40

Jan 18, 2008
Special Summer Catch-Up Edition

Dec 21
FDA N9 Warning
Good For Starpharma
Vaginal Gel

Dec 20
Prana Adds Cancer
To Pipeline;
Fermiscan Best Test
For Breast Cancer

Dec 13
Marc Sinatra’s Bioguide:
Novogen -
Catching A Falling Knife

November 27, 2007
Psivida AGM Faces
Tough Questions

November 26, 2007
Avexa Rebutts Bioshares:
‘No Registration Delays’ 

November 22, 2007
FDA Approves
Bionomics
Cancer Trial

November 8, 2007
Acrux Gives
Smoking
A Spray

October 22, 2007
Living Cell Patient
'Insulin-Free',
Shares Jump 61%

May 22, 2007
World Firsts for Peptech, Living Cell

May 21, 2007
Imugene Vaccine 100% Effective Against H5N1

May 7, 2007
Peptech-Evogenix Merger; Think Fink On Stress;
Wallaby Milk Kills Superbugs

May 4, 2007
Victoria Approves Therapeutic Cloning

May 2, 2007
Novogen’s Phenoxodiol Causes Cancer Cell Death

May 1, 2007
Biotechs Double All Ords in April

April 26, 2007
Alchemia’s Hat-Trick: ‘Startling’ Cancer Results, New Distributor, New CEO 

April 24, 2007
Resmed’s $72m Recall

April 18, 2007
CSL’ Gardasil May Prevent 80% of Cervical Cancers